Aims: To evaluate the efficacy of two alkylating structural analogues of chloramphenicol that have potential for application for treatment of dermal sited neoplasms.
Study Design: Two compounds have been shown to alkylate guanosine-5’-diphosphate (GDP) at physiological conditions. These same compounds are evaluated for dermal penetration based on Kp and compared to other alkylating agents applied for treatment of skin cancer.
Placeand Duration of Study: University of Nebraska, Omaha Nebraska from December 2013 to May 2014 and March to August of 2002.
Methodology: Two analogues of chloramphenicol were synthesized and shown to alkylate GDP at pH 7.4 and 37ºC. Various pharmacologicalproperties of these two analogues, such as Log P, molecular weight, polar surface area, etc, were determined and compared. The dermal permeability coefficient Kp was determined for two analogues based on their molecular weight and partition coefficient Log P. The numerical values of Kp were used to prediction of the distance each analogue is expected to travel in penetration of a dermal barrier. Result was plotted and compared to the anticancer agent’s carmustine, mustargen, and 5-fluorouracil. Evaluationof the analogues included findings of previous studies.
Results: Two analogues of chloramphenicol alkylate sites on GDP. The properties of compound 1 and compound 2 were determined and when compared to the parent structure chloramphenicol were found tohave favorable drug likeness. Values of Log P and permeability coefficient Kp for compounds 1 and 2 are; 3.343, 3.312, 0.00244 cm/hour, 0.000768 cm/hour, respectively. Values of Kp for both compound 1 and 2 were greater than that of chloramphenicol at 0.000131 cm/hour. Plots of skin penetration showed compounds 1 and 2 to be superior to 5-fluorouracil.
Conclusion: Analogues 1 and 2 were shown to have alkylation activity and properties suitable for drug likeness. Both compounds have high penetration ratesof dermal layers. The pharmaceutical properties of two structural analogues of the antibiotic chloramphenicol were determined and analyzed for potential of topical administration. Compound 1 and compound 2 were both shown in previous studies to alkylate guanosine-5’-diphosphate, amino acids, and p-chloroaniline. Both analogues 1 and 2 possess alkyl chloride substituents in place of hydroxyl groups found on chloramphenicol. Dermal permeability coefficient Kp of analogue 1 (0.00244 cm/hour) is greater than Kp for carmustine, Mustargen, and 5-fluorouracil. Analogue 2 value of Kp (0.000768 cm/hour) is greater than Kp for anticancer drug 5-fluorouracil. The diffusion coefficient D for analogue 1 and 2 are competitive with those of carmustine, Mustargen, and 5-fluorouracil. Aqueous solubility of analogues 1 and 2 are considerably lower than for chloramphenicol, which is consistent with the much larger Log P values for 1 and 2. Plots of distance traveled, based on their values of Kp, showed that compound 1 moves further than carmustine, Mustargen, and 5-fluorouracil. Compound 2 still travels further than chloramphenicol and anticancer agent 5-fluorouracil. These results strongly support the potential of compound 1 and 2 as effective topical agents in treatment of skin neoplasms and mycosis fungoides.
Biography of author(s)
University of Nebraska, Durham Science Center, Department of Chemistry, 6001 Dodge Street, Omaha, NE 68182, USA.
Read full article: http://bp.bookpi.org/index.php/bpi/catalog/view/47/231/396-1
View volume: https://doi.org/10.9734/bpi/mapr/v1